Back to Journals » Journal of Hepatocellular Carcinoma » Volume 6 » default

Impact Factor

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969

Archive: Volume 6, 2019

Review

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

El Kassas M, Tawheed A, Eltabbakh M, Kaseb A

Journal of Hepatocellular Carcinoma 2019, 6:183-191

Published Date: 19 November 2019

Original Research

Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida

Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E

Journal of Hepatocellular Carcinoma 2019, 6:167-181

Published Date: 15 November 2019

Review

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine

Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S

Journal of Hepatocellular Carcinoma 2019, 6:151-166

Published Date: 18 October 2019

Original Research

Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study

Million Y, Teklu T, Alemu S, Ferede A, Belachew T, Desta K

Journal of Hepatocellular Carcinoma 2019, 6:143-150

Published Date: 8 October 2019

Review

Status of, and strategies for improving, adherence to HCC screening and surveillance

Francica G, Borzio M

Journal of Hepatocellular Carcinoma 2019, 6:131-141

Published Date: 24 July 2019

Original Research

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma

Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M

Journal of Hepatocellular Carcinoma 2019, 6:119-129

Published Date: 22 July 2019

Review

Intermediate stage hepatocellular carcinoma: a summary review

Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I

Journal of Hepatocellular Carcinoma 2019, 6:105-117

Published Date: 11 July 2019

Original Research

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK

Journal of Hepatocellular Carcinoma 2019, 6:93-103

Published Date: 17 June 2019

Review

Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma

Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML

Journal of Hepatocellular Carcinoma 2019, 6:85-91

Published Date: 6 June 2019

Review

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

Lu LC, Chang CJ, Hsu CH

Journal of Hepatocellular Carcinoma 2019, 6:71-84

Published Date: 7 May 2019

Review

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB

Journal of Hepatocellular Carcinoma 2019, 6:49-69

Published Date: 5 February 2019

Meeting Report